Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NFATC3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | EFCAB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CPLX2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SLK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | GRIN1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | RPL4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CNOT8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | DLAT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZNF630 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | VRK3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |